Exodus Point Capital Management, LP Idera Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.53 - $1.03 $13,692 - $26,610	-25,835 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $11,906 - $14,049	11,906 Added 85.48%	25,835 $27,000
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $15,613 - $24,425	-15,459 Reduced 52.6%	13,929 $17,000
Q1 2021 May 17, 2021	SELL	$1.23 - $5.98 $5,216 - $25,361	-4,241 Reduced 12.61%	29,388 $38,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $70,284 - $174,198	33,629 New	33,629 $123,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.